B cell depletion therapy in systemic lupus erythematosus.
about
Pregnancy Associated with Systemic Lupus Erythematosus: Immune Tolerance in Pregnancy and Its Deficiency in Systemic Lupus Erythematosus--An Immunological DilemmaPharmacogenetics/pharmacogenomics and antirheumatic drugs in rheumatology.Novel therapies in lupus nephritis.Emergence of targeted immune therapies for systemic lupus.Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis.Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports.B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosusDevelopment of biologicals for the therapy of lupus erythematosus.An open-label trial of rituximab therapy in pulmonary alveolar proteinosis.Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.Treatment of refractory pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab): five cases.Persistent memory B cell down-regulation after 6-year remission induced by rituximab therapy in patients with systemic lupus erythematosus.Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis.Characterization of the B-cell inhibitory protein factor in Ixodes ricinus tick saliva: a potential role in enhanced Borrelia burgdoferi transmission
P2860
Q35671572-23709C3F-9423-468A-9C90-2B507F22B18EQ35976402-22552E28-8960-46E6-B16D-DC55047CD0BAQ36054877-BD1A177F-F03D-4761-BCFB-7FBCF17BE1C5Q36066014-F53FA23C-4AFE-432C-9242-C05A0FE5081FQ36204781-71CAFA5D-0472-4409-8288-D52D4DE0339EQ36460981-9AB7A783-36FF-4110-8056-424459061306Q36577391-D45609A3-6540-4DB9-B6AD-6F28A229D980Q36752014-07A98905-BAA9-4126-8408-38E835AA4F71Q36993242-5887AE98-F3A3-443C-803F-D16BAB4BD3DAQ37012093-DAD4BFD3-1860-4914-8EF1-ED4FD46DD99CQ37418292-F197D79A-1B11-4FE5-97DC-861733152E11Q38466691-E76E049E-8370-47AF-AEFF-E4CB1BCA42FFQ40208068-0225CE45-EC64-4A34-A6F7-6D1C007B06C5Q50913061-3758185F-DF18-4540-AF4C-888ADAFF1318Q50980453-9EA2CDD2-BAF6-4B54-A786-CF4539831A71Q58848726-917F189E-7CC4-4ABC-8A07-B5D05976211E
P2860
B cell depletion therapy in systemic lupus erythematosus.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
B cell depletion therapy in systemic lupus erythematosus.
@ast
B cell depletion therapy in systemic lupus erythematosus.
@en
type
label
B cell depletion therapy in systemic lupus erythematosus.
@ast
B cell depletion therapy in systemic lupus erythematosus.
@en
prefLabel
B cell depletion therapy in systemic lupus erythematosus.
@ast
B cell depletion therapy in systemic lupus erythematosus.
@en
P2093
P1476
B cell depletion therapy in systemic lupus erythematosus.
@en
P2093
Iñaki Sanz
Jennifer Anolik
R John Looney
P2860
P2888
P304
P356
10.1007/S11926-003-0020-X
P577
2003-10-01T00:00:00Z